泛素连接酶NEDD4在抗体类型转换和CD40信号通路中的调节作用及机制研究

基本信息
批准号:31400744
项目类别:青年科学基金项目
资助金额:25.00
负责人:方迪峰
学科分类:
依托单位:中国人民解放军军事科学院军事医学研究院
批准年份:2014
结题年份:2017
起止时间:2015-01-01 - 2017-12-31
项目状态: 已结题
项目参与者:穆蕊,桑志红,杨扬,吴瑾,黄燕
关键词:
CD40抗体类型转换B细胞NEDD4AKT
结项摘要

Immunoglobulin class switch, which is essential for humoral immunity, generates changes in the immunoglobulin expressed and the biological effector functions of immunoglobulin molecule without changing its specificity. CD40 is a major in vivo inducer of immunoglobulin class switch and abnormal CD40 signaling resulting immunodeficiency disorder, such as hyper-IgM syndrome. However, the regulation of CD40-mediated class switch is not fully understood and a molecular and biochemical understanding of CD40 signaling is lacking. Here we find that, in vivo and in vitro, E3 ubiquitin ligase NEDD4 is involved in immunoglobulin class switch, CD40-mediated AKT activation, and TRAF3 poly-ubiquitination. Upon these observation, we try to investigate the roles of NEDD4 in thymus-dependent immunoglobulin class switch, B cell survival, B cell proliferation, germinal center formation and plasmacytic differentiation through Nedd4 knockout mice and cells. Furthermore, using co-IP, ubiquitination assay and detecting CD40-mediated signaling, we try to clarify the form of NEDD4-mediated TRAF3 ubiquitination and its contribution to CD40 signaling pathway. In summary, this project propose that through ubiquitinating TRAF3, NEDD4 controls CD40-AKT signaling which regulate B cell immunoglobulin class switch.

抗体类型转换在体液免疫中发挥重要作用,该机制在不改变抗体特异性的情况下转换成不同类型的抗体,继而产生抗体的不同生物学效应。CD40信号通路是B细胞抗体类型转换的重要诱导因素之一,通路异常可导致高IgM血症等免疫缺陷相关疾病。但是,CD40介导的抗体类型转换和CD40信号通路调控机制并不完全清楚。我们前期研究发现:泛素连接酶NEDD4敲除细胞和动物中抗体类型转换能力增强;NEDD4调控CD40介导AKT激活,促进CD40信号通路重要调节蛋白质TRAF3泛素化。在此基础上,本项目拟在敲除动物和细胞水平深入研究NEDD4对B细胞功能的调节作用,包括抗体类型转换、B细胞增殖与存活、生发中心形成和浆细胞分化等。通过免疫共沉淀、泛素化和CD40信号通路激活检测,探讨NEDD4对TRAF3泛素化修饰方式及其对下游信号通路激活的调控机制。本研究有可能发现调控CD40信号通路和B细胞功能的全新分子机制。

项目摘要

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

Protective effect of Schisandra chinensis lignans on hypoxia-induced PC12 cells and signal transduction

Protective effect of Schisandra chinensis lignans on hypoxia-induced PC12 cells and signal transduction

DOI:10.1080/15287394.2018.1502561
发表时间:2018
2

The Role of Osteokines in Sarcopenia: Therapeutic Directions and Application Prospects

The Role of Osteokines in Sarcopenia: Therapeutic Directions and Application Prospects

DOI:10.3389/fcell.2021.735374
发表时间:2021
3

视网膜母细胞瘤的治疗研究进展

视网膜母细胞瘤的治疗研究进展

DOI:
发表时间:2018
4

Baicalin provides neuroprotection in traumatic brain injury mice model through Akt/Nrf2 pathway

Baicalin provides neuroprotection in traumatic brain injury mice model through Akt/Nrf2 pathway

DOI:10.2147/DDDT.S163951
发表时间:2018
5

Bousangine A, a novel C-17-nor aspidosperma-type monoterpenoid indole alkaloid from Bousigonia angustifolia

Bousangine A, a novel C-17-nor aspidosperma-type monoterpenoid indole alkaloid from Bousigonia angustifolia

DOI:10.1016/j.fitote.2020.104491
发表时间:2020

方迪峰的其他基金

相似国自然基金

1

Nedd4类E3泛素连接酶在肿瘤发生发展中的作用机制的研究

批准号:81272248
批准年份:2012
负责人:王洪睿
学科分类:H1802
资助金额:16.00
项目类别:面上项目
2

拟南芥泛素连接酶ROBIN1在BR信号通路中的功能与机制研究

批准号:31870253
批准年份:2018
负责人:李建明
学科分类:C0206
资助金额:60.00
项目类别:面上项目
3

泛素连接酶Nrdp1/DRP在巨噬细胞TLR信号传导中的调节作用研究

批准号:30771118
批准年份:2007
负责人:陈涛涌
学科分类:C0702
资助金额:28.00
项目类别:面上项目
4

E3泛素连接酶NEDD4调控神经元细胞周期重返及凋亡的机制研究

批准号:31201018
批准年份:2012
负责人:邓其跃
学科分类:C0703
资助金额:23.00
项目类别:青年科学基金项目